These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9020898)

  • 21. HLA-DRB alleles are differentially expressed by tumor cells in breast carcinoma.
    Oldford SA; Robb JD; Watson PH; Drover S
    Int J Cancer; 2004 Nov; 112(3):399-406. PubMed ID: 15382064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
    Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
    Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
    Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
    Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
    Momburg F; Möller P
    Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.
    Angevin E; Kremer F; Gaudin C; Hercend T; Triebel F
    Int J Cancer; 1997 Jul; 72(3):431-40. PubMed ID: 9247286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules.
    Catálfamo M; Serradell L; Roura-Mir C; Kolkowski E; Sospedra M; Vives-Pi M; Vargas-Nieto F; Pujol-Borrell R; Jaraquemada D
    Int Immunol; 1999 Feb; 11(2):269-77. PubMed ID: 10069425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferon-induced protection of renal cell cancer cell lines to lymphokine-activated killer (LAK) cells and effect of acid treatment on their susceptibility. Its relevance to expression of major histocompatibility complex class I antigens on tumor cells].
    Tomita Y; Kimura M; Nishiyama T; Sato S
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):762-8. PubMed ID: 1908533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human renal-cell carcinoma cells are able to activate natural killer cells.
    Hayakawa K; Morita T; Augustus LB; von Eschenbach AC; Itoh K
    Int J Cancer; 1992 May; 51(2):290-5. PubMed ID: 1533204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Wu XX; Zeng Y; Jin XH; Kakehi Y
    Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an enriched CD4+ CD8alpha++ CD8beta+ T-cell subset among tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Dal Cin P; Van den Berghe H; Ceuppens JL
    Int J Cancer; 1997 Apr; 71(2):178-82. PubMed ID: 9139839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
    Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
    J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
    Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
    Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.
    Sekaly RP; Tonnelle C; Strubin M; Mach B; Long EO
    J Exp Med; 1986 Nov; 164(5):1490-504. PubMed ID: 2430042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivo.
    Reinisch W; Lichtenberger C; Steger G; Tillinger W; Scheiner O; Gangl A; Maurer D; Willheim M
    Clin Exp Immunol; 2003 Sep; 133(3):476-84. PubMed ID: 12930377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer.
    Tomita Y; Nishiyama T; Fujiwara M; Sato S
    Br J Cancer; 1990 Sep; 62(3):354-9. PubMed ID: 2206942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
    Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
    Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DM is expressed on the cell surface and colocalizes with HLA-DR and invariant chain in human Langerhans cells.
    Andersson T; Patwardhan A; Emilson A; Carlsson K; Scheynius A
    Arch Dermatol Res; 1998 Dec; 290(12):674-80. PubMed ID: 9879837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.